Skip to content
TrialScanner

NCT04153149

HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

Phase 3Active, not recruitingALNYLead

Registry record

Lead sponsor
Alnylam Pharmaceuticals
Conditions
Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
Primary completion
May 8, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04153149 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04153149: HELIOS-B: A Study to... | TrialScanner